110 related articles for article (PubMed ID: 1422063)
1. Protection from rabies by a vaccinia virus recombinant containing the rabies virus glycoprotein gene. 1984.
Wiktor TJ; MacFarlan RI; Reagan KJ; Dietzschold B; Curtis PJ; Wunner WH; Kieny MP; Lathe R; Lecocq JP; Mackett M
Biotechnology; 1992; 24():508-12. PubMed ID: 1422063
[No Abstract] [Full Text] [Related]
2. Generation and evaluation of a recombinant modified vaccinia virus Ankara vaccine for rabies.
Weyer J; Rupprecht CE; Mans J; Viljoen GJ; Nel LH
Vaccine; 2007 May; 25(21):4213-22. PubMed ID: 17434244
[TBL] [Abstract][Full Text] [Related]
3. [Recombinant replication-defective adenovirus based rabies vaccine].
Li WH; Zhang Y; Wang SH; Liu L; Yang F
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Dec; 25(6):650-4. PubMed ID: 14714304
[TBL] [Abstract][Full Text] [Related]
4. [Immune response of mice to replication-defective recombinant adenovirus containing glycoprotein gene of rabies virus 3aG strain].
Li W; Zhang Y; Wang S
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2001 Mar; 15(1):61-5. PubMed ID: 12526306
[TBL] [Abstract][Full Text] [Related]
5. [Construction and characterization of non-replicating recombinant vaccinia virus expressing rabies glycoprotein].
Li P; Hu Q; Sun Z
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1999 Jun; 13(2):170-4. PubMed ID: 12569788
[TBL] [Abstract][Full Text] [Related]
6. Deliberate release of a recombinant vaccinia-rabies virus for vaccination of wild animals against rabies.
Pastoret PP; Brochier B; Coppens P
Microb Releases; 1993 Mar; 1(4):191-5. PubMed ID: 8281357
[TBL] [Abstract][Full Text] [Related]
7. Human infection due to recombinant vaccinia-rabies glycoprotein virus.
Rupprecht CE; Blass L; Smith K; Orciari LA; Niezgoda M; Whitfield SG; Gibbons RV; Guerra M; Hanlon CA
N Engl J Med; 2001 Aug; 345(8):582-6. PubMed ID: 11529212
[No Abstract] [Full Text] [Related]
8. A single immunization with a recombinant canine adenovirus expressing the rabies virus G protein confers protective immunity against rabies in mice.
Li J; Faber M; Papaneri A; Faber ML; McGettigan JP; Schnell MJ; Dietzschold B
Virology; 2006 Dec 5-20; 356(1-2):147-54. PubMed ID: 16938327
[TBL] [Abstract][Full Text] [Related]
9. Protective efficacy in mice of post-exposure vaccination with vaccinia virus recombinant expressing either rabies virus glycoprotein or nucleoprotein.
Fujii H; Takita-Sonoda Y; Mifune K; Hirai K; Nishizono A; Mannen K
J Gen Virol; 1994 Jun; 75 ( Pt 6)():1339-44. PubMed ID: 8207400
[TBL] [Abstract][Full Text] [Related]
10. Expression of glycoprotein gene of the rabies virus 3aG strain by E-3 deleted adenovirus recombinant.
Zhang X; Zhang Y; Li W
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2000 Sep; 14(3):281-4. PubMed ID: 11498699
[TBL] [Abstract][Full Text] [Related]
11. Control of rabies in wildlife.
Winkler WG; Bögel K
Sci Am; 1992 Jun; 266(6):86-92. PubMed ID: 1585150
[No Abstract] [Full Text] [Related]
12. Vaccination with a plasmid vector carrying the rabies virus glycoprotein gene induces protective immunity against rabies virus.
Xiang ZQ; Spitalnik S; Tran M; Wunner WH; Cheng J; Ertl HC
Virology; 1994 Feb; 199(1):132-40. PubMed ID: 8116236
[TBL] [Abstract][Full Text] [Related]
13. A DNA vaccine that encodes rabies virus glycoprotein lacking transmembrane domain enhances antibody response but not protection.
Gupta PK; Sharma S; Walunj SS; Patil AA; Rai A; Saini M
Acta Virol; 2006; 50(2):87-92. PubMed ID: 16808325
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the protective efficacy between single and combination of recombinant adenoviruses expressing complete and truncated glycoprotein, and nucleoprotein of the pathogenic street rabies virus in mice.
Kim HH; Yang DK; Nah JJ; Song JY; Cho IS
Virol J; 2017 Jun; 14(1):122. PubMed ID: 28646885
[TBL] [Abstract][Full Text] [Related]
15. [Development and preliminary assessment of a recombinant canarypox virus as an antirabic vaccine candidate].
Zanetti F; Rudak L; Micucci M; Grand DC; Luque A; Russo S; Taboga O; Pérez O; Calamante G
Rev Argent Microbiol; 2012; 44(2):75-84. PubMed ID: 22997764
[TBL] [Abstract][Full Text] [Related]
16. Development of rabies DNA vaccine using a recombinant plasmid.
Rai N; Kaushik P; Rai A
Acta Virol; 2005; 49(3):207-10. PubMed ID: 16178518
[TBL] [Abstract][Full Text] [Related]
17. [A recombinant vaccinia virus expressing the middle preS2-S envelope protein of the hepatitis B virus. The induction of humoral and cellular immunity by the immunization of laboratory animals].
Beliaev AS; Dmitriev IP; Ignat'ev GM; Mizenko GA; Putintseva NI; Sabirov AN; Samukov VV; Semënova LN; Ammosov AD; Rukavishnikov MIu
Dokl Akad Nauk SSSR; 1990; 314(2):488-91. PubMed ID: 2265587
[No Abstract] [Full Text] [Related]
18. Gene immunization of mice with plasmid DNA expressing rabies virus glycoprotein.
Fodor I; Kucsera L; Fodor N; Pálfi V; Grabko VI
Acta Vet Hung; 2000; 48(2):229-36. PubMed ID: 11402706
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the immunogenicity of two inactivated recombinant rabies viruses overexpressing the glycoprotein.
Navid MT; Li Y; Zhou M; Cui M; Fu ZF; Tang L; Zhao L
Arch Virol; 2016 Oct; 161(10):2863-70. PubMed ID: 27438075
[TBL] [Abstract][Full Text] [Related]
20. A novel rabies vaccine based on a recombinant parainfluenza virus 5 expressing rabies virus glycoprotein.
Chen Z; Zhou M; Gao X; Zhang G; Ren G; Gnanadurai CW; Fu ZF; He B
J Virol; 2013 Mar; 87(6):2986-93. PubMed ID: 23269806
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
